Wildflower Brings CBD to Manhattan With Retail Worx

VANCOUVER, British Columbia, July 10, 2018 (GLOBE NEWSWIRE) -- Wildflower Brands Inc. (CSE:SUN) (the “Company”) has signed a letter of intent with Retail Worx to retail Wildflower cannabidiol (CBD) products at prime Manhattan locations.  New York, with its dense population of affluent wellness-minded professionals is ideal for retailing Wildflower’s hemp-based CBD+ Wellness product line.  Wildflower’s highest volume retailer is located in Manhattan and its largest social following comes from New York.  This places a high priority on expansion into New York due to the population’s existing awareness and focus on holistic health and wellness.

Retail Worx will be converting up to three of their highest traffic locations into Wildflower wellness stores.  The first is in Times Square at the Microsoft and E*Trade building across from the New York Times.  The second will be in a NoHo property anchored by Facebook’s NY headquarters where up to 14,000 Facebook employees work along with digital media professionals from the Huffington Post, Yahoo and AOL who also occupy this building.  There will be an option on a third location located in the Flatiron district in the iconic Eleven Madison building.  Retail Worx will also launch Wildflower products into their five Bridges General stores and kiosks located in Class A office towers throughout Manhattan.

With Retail Worx knowledge and guidance, the stores will reach a demographic of foot traffic identified at these locations that are in Wildflower’s target market: educated busy professionals who are conscious of wellness as a foundation of success in life.

Wildflower will pay for the re-development of the three retail locations to brand them under the “Wildflower” name.  Further, the parties agree to collaborate on various marketing initiatives and additional Wildflower product distribution opportunities.  As part of this arrangement Wildflower will grant 800,000 share purchase warrants exercisable at $1.50 for a period of one year, as to 200,000 issuable immediately, 200,000 issuable after 6 months provided Wildflower branded stores continue to operate and 400,000 issuable after one year provided Wildflower branded stores continue to operate.

William MacLean, CEO of Wildflower says, “This partnership with Retail Worx is exciting to us because they have very similar values as the Wildflower team and compliments us with their deep expertise in retail. By working together we will build a CBD retail experience that simply does not exist today. This is groundbreaking in giving consumers accessible information and guidance in CBD Wellness solutions.”

ABOUT RETAIL WORX

Retail Worx is an innovative private company that is changing the retail landscape by creating meaningful lifestyle experiences for today’s conscious consumers.

Jonathan Krieger, CEO of Retail Worx adds, “We are thrilled to be partnering with Wildflower and creating a unique partnership for our retail stores. Wildflower and Retail Worx have a passion for experiential retail and the highest quality products. At Bridges General we are recreating the convenience store with next level design and development of retail for today's consumer."

"Bridges General and Wildflower are embarking on an exciting retail journey to introduce the highest quality CBD product set to NYC. In today's fast paced environment the need for health and wellness products are more important than ever and this product line offers an incredible opportunity for people to experience the benefits of CBD. Wildflower is the obvious choice for us and as we continue to build our retail stores this becomes an essential part of our core brand offerings."

"Education and the pursuit of the highest quality products, ingredients and experiences is the foundation of Bridges General and all Retail Worx brands and we are excited to partner with Wildflower to bring their CBD line of products to NYC and North America."

ABOUT WILDFLOWER

Wildflower is a cannabis company focused on developing and designing branded products in the cannabis and healthcare sectors.  We develop proprietary product lines using THC or CBD by taking traditional herbal medicines and applying the most advanced science, technology and know-how to create quality products for the health conscious consumer. Wildflower works exclusively in jurisdictions where cannabis is legal or regulated. 

On Behalf of the Board of Directors

“William MacLean”

____________________________________

William MacLean

Director and CEO

THIS NEWS RELEASE, PROVIDED PURSUANT TO APPLICABLE CANADIAN REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S. NEWS SERVICES OR FOR DISSEMINATION IN THE UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION OR APPLICABLE EXEMPTION FROM REGISTRATION REQUIREMENTS.

Cautionary and Forward-Looking Statements

This news release contains forward‐looking statements and forward‐looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward‐looking statements or information. Forward‐looking statements and information are often, but not always, identified by the use of words such as "appear", "seek", "anticipate", "plan", "continue", "estimate", "approximate", "expect", "may", "will", "project", "predict", "potential", "targeting", "intend", "could", "might", "should", "believe", "would" and similar expressions.

Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward‐looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to, the risks associated with the marijuana industry in general such as operational risks in growing; competition; incorrect assessment of the value and potential benefits of various transactions; ability to access sufficient capital from internal and external sources; failure to obtain required regulatory and other approvals and changes in legislation, including but not limited to tax laws and government regulations. Accordingly, readers should not place undue reliance on the forward‐looking statements, timelines and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive.

The forward‐looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward‐looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws or the Canadian Securities Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.

The Canadian Securities Exchange Inc. has in no way passed upon the merits of the proposed transaction and has neither approved nor disapproved of the contents of this press release.